Immuno-Biological Laboratories Co., Ltd. Logo

Immuno-Biological Laboratories Co., Ltd.

Develops and supplies immunological reagents and diagnostics for research and drug discovery.

4570 | T

Overview

Corporate Details

ISIN(s):
JP3921300004
LEI:
Country:
Japan
Address:
藤岡市中字東田1091番地1
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Immuno-Biological Laboratories Co., Ltd. (IBL) is a research-driven company that develops, manufactures, and supplies immunological research reagents and diagnostics. The company's portfolio includes ELISA kits, specialized antibodies, and cell culture-related products. IBL focuses on key therapeutic areas such as aging, neurodegenerative disorders, kidney diseases, inflammatory diseases, and glucose/lipid metabolism. A notable offering is the LipoSEARCH® lipoprotein analyzing system, which utilizes patented Gel Permeation High-Performance Liquid Chromatography (GP-HPLC) technology. The company collaborates with pharmaceutical partners and research institutions to support drug discovery and the development of novel diagnostics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-14 01:09
Report Publication Announcement
確認書
Japanese 8.7 KB
2025-11-14 01:07
Interim Report
半期報告書-第44期(2025/04/01-2026/03/31)
Japanese 173.9 KB
2025-06-27 06:30
Post-Annual General Meeting Information
臨時報告書
Japanese 23.0 KB
2025-06-27 02:05
Governance Information
内部統制報告書-第43期(2024/04/01-2025/03/31)
Japanese 25.4 KB
2025-06-27 02:04
Registration Form
確認書
Japanese 8.7 KB
2025-06-27 02:02
Annual Report
有価証券報告書-第43期(2024/04/01-2025/03/31)
Japanese 1.2 MB
2024-11-14 01:04
Report Publication Announcement
確認書
Japanese 8.7 KB
2024-11-14 01:02
Interim Report
半期報告書-第43期(2024/04/01-2025/03/31)
Japanese 180.6 KB
2024-06-26 03:44
Post-Annual General Meeting Information
臨時報告書
Japanese 23.0 KB
2024-06-26 03:41
Governance Information
内部統制報告書-第42期(2023/04/01-2024/03/31)
Japanese 23.7 KB
2024-06-26 03:40
Registration Form
確認書
Japanese 8.7 KB
2024-06-26 03:38
Registration Form
有価証券報告書-第42期(2023/04/01-2024/03/31)
Japanese 1.2 MB
2024-02-14 01:10
Report Publication Announcement
確認書
Japanese 8.7 KB
2024-02-14 01:07
Quarterly Report
四半期報告書-第42期第3四半期(2023/10/01-2023/12/31)
Japanese 161.4 KB
2023-11-14 01:02
Report Publication Announcement
確認書
Japanese 8.7 KB

Automate Your Workflow. Get a real-time feed of all Immuno-Biological Laboratories Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Immuno-Biological Laboratories Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Immuno-Biological Laboratories Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden
ACTI
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing a novel GSK-3 inhibitor for hard-to-treat cancers.
United States of America
ACTU
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden
ACUC
Acurx Pharmaceuticals, Inc. Logo
Developing a new class of antibiotics to treat priority Gram-positive bacterial infections.
United States of America
ACXP
Adagene Inc. Logo
Develops novel antibody-based immunotherapies for cancer using an AI-driven discovery platform.
United States of America
ADAG
Adaptimmune Therapeutics PLC Logo
Develops novel T-cell therapies to treat solid tumors by engineering a patient's own immune cells.
United States of America
ADAP
ADBIOTECH Co.,Ltd. Logo
Develops egg-based IgY antibodies as vaccine/antibiotic alternatives for animal and human health.
South Korea
179530
ADC Therapeutics SA Logo
Develops targeted antibody-drug conjugates for hematological and solid tumors.
United States of America
ADCT
ADIAL PHARMACEUTICALS, INC. Logo
Develops personalized, genetically-targeted drugs for treating Alcohol Use Disorder and addiction.
United States of America
ADIL
Adicet Bio, Inc. Logo
Developing off-the-shelf gamma delta T cell therapies for cancer and autoimmune diseases.
United States of America
ACET

Talk to a Data Expert

Have a question? We'll get back to you promptly.